⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL124683 | 1.00 | — | — | |
| SCHEMBL805878 | 1.00 | — | — | |
| SCHEMBL28040463 | 1.00 | — | — | |
| SCHEMBL2985745 | 1.00 | — | — | |
| SCHEMBL22162 | 1.00 | — | — | |
| SCHEMBL283825 | 1.00 | — | — | |
| SCHEMBL3427685 | 1.00 | ALDH1A1 (0.62) | — | |
| Isopropyl Alcohol SCHEMBL10704262 | 0.94 | ALDH1A1 (0.75) | — | |
| Water SCHEMBL18210533 | 0.94 | — | — | |
| Methane SCHEMBL15522521 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 647 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4744488-A1 | COMPOSITION AND STARTING MATERIAL COMPOSITION OF COSMETIC | IBIDEN CO., LTD. (JP) | 2026-05-20 | — | — | EP | claimed |
| US-12441681-B2 | Synthesis of sulfonamide intermediates | AMGEN INC. (US) | 2025-10-14 | — | — | US | claimed |
| CN-115820582-B | Alcohol dehydrogenase mutant and application thereof | 浙江大学杭州国际科创中心 | 2025-04-29 | — | — | CN | claimed |
| WO-2025018263-A1 | COMPOSITION AND STARTING MATERIAL COMPOSITION OF COSMETIC | イビデン株式会社 | 2025-01-23 | — | — | WO | claimed |
| WO-2025018264-A1 | COMPOSITION, RAW MATERIAL COMPOSITION OF COSMETIC, VIRUS PROLIFERATION SUPPRESSING AGENT, USE OF COMPOSITION FOR SUPPRESSING VIRUS PROLIFERATION, METHOD FOR SUPPRESSING VIRUS PROLIFERATION, AND SEALED BODY | イビデン株式会社 | 2025-01-23 | — | — | WO | claimed |
| CN-115515931-B | Synthesis of sulfonamide intermediates | 安进公司 | 2024-10-18 | — | — | CN | claimed |
| CN-117524570-B | High-temperature-resistant double-layer ceramic mica fireproof wire | 温州网牌电线电缆有限公司 | 2024-08-16 | — | — | CN | claimed |
| WO-2024113409-A1 | ALCOHOL DEHYDROGENASE MUTANT AND USE THEREOF | 浙江大学杭州国际科创中心 | 2024-06-06 | — | — | WO | claimed |
| CN-117524570-A | High-temperature-resistant double-layer ceramic mica fireproof wire | 温州网牌电线电缆有限公司 | 2024-02-06 | — | — | CN | claimed |
| US-20230357137-A1 | Synthesis of Sulfonamide Intermediates | AMGEN INC. (US) | 2023-11-09 | — | — | US | claimed |
| US-20020141952-A1 | Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues | APPLIED GENETICS INCORPORATED DERMATICS | 2002-10-03 | — | — | US | claimed |
| WO-2002051395-A1 | TREATMENT OF NEURODEGENERATIVE DISEASES | CODON PHARMACEUTICALS, INC. (US) | 2002-07-04 | — | — | WO | claimed |
| EP-0957903-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | Codon Pharmaceuticals, Inc. (US) | 1999-11-24 | — | — | EP | claimed |
| US-5990177-A | CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM | CODON PHARMACEUTICALS, INC. (US) | 1999-11-23 | — | — | US | claimed |
| WO-1998055085-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-12-10 | — | — | WO | claimed |
| WO-1998011882-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-03-26 | — | — | WO | claimed |
| EP-0373915-B1 | NOVEL THROMBOXANE A2 ANTAGONISTS | BTG INTERNATIONAL LIMITED (GB) | 1993-08-18 | — | — | EP | claimed |
| US-4992581-A | From perhydroketo-4,7-methanoindene | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1991-02-12 | — | — | US | claimed |
| WO-1990006917-A1 | NOVEL THROMBOXANE A2 ANTAGONISTS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1990-06-28 | — | — | WO | claimed |
| EP-0373915-A1 | Novel thromboxane A2 antagonists | BTG INTERNATIONAL LIMITED (GB) | 1990-06-20 | — | — | EP | claimed |